Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00409045 · ClinicalTrials.gov registry record

Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism

A clinical trial of Obstructive Sleep Apnea and Pulmonary Embolism, sponsored by Atlantic Health System.

Completed
Registry status
300
Enrollment target
1
Study location

NCT00409045 is a study of Obstructive Sleep Apnea and Pulmonary Embolism that has completed, run by Atlantic Health System. The registered enrollment target is 300 participants, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00409045, a study of Obstructive Sleep Apnea and Pulmonary Embolism, has completed, sponsored by Atlantic Health System.

COMPLETED
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

we evaluate the presence of OSA in patients that have a computed tomography (CT) of the chest to rule out pulmonary embolism (PE) to determine if OSA constitutes an independent risk factor for PE.

Study Locations (1)

New Jersey

  • Morristown Memorial Hospital - Morristown

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2005-11
Est. Completion 2007-09

Sponsor

Atlantic Health System

43 total trials

What the Registry Record Tells You About NCT00409045

The ClinicalTrials.gov registry entry for NCT00409045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (36% higher). The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.

NCT00409045 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00409045 about?

NCT00409045 is a clinical study titled "Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism". we evaluate the presence of OSA in patients that have a computed tomography (CT) of the chest to rule out pulmonary embolism (PE) to determine if OSA constitutes an independent risk factor for PE.

What is the current status of trial NCT00409045?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2005-11. Estimated completion is 2007-09.

What conditions does trial NCT00409045 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Pulmonary Embolism.

Who is sponsoring clinical trial NCT00409045?

This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00409045 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.